Prelude Capital Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,555
Closed -$77.9K 1319
2024
Q1
$77.9K Buy
+25,555
New +$77.9K ﹤0.01% 1112